EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate structure, CAS 1079083-63-8

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

CAS Number1079083-63-8

Synonyms

Molecular FormulaC27H29O10Cl1

Molecular Weight548.97

Purity

Density

Boiling Point

Melting Point149-151 °C

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-3180321 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 1079083-63-8 ] SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number1079083-63-8
Catalog No.2A-3180321
Chinese Name(2R,3R,4R,5S,6S)-2-(乙酰氧基甲基)-6-(4-氯-3-(4-羟基苄基)苯基)四氢-2H-吡喃-3,4,5-三乙酸三酯
Molecular FormulaC27H29O10Cl1
Molecular Weight548.97
Melting Point149-151 °C
Storage Condition2-8°C, stored under nitrogen
PubChem ID224514256
MDL NumberMFCD35099684
SMILESCC(=O)OCC1OC(c2ccc(Cl)c(Cc3ccc(O)cc3)c2)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O
InChIInChI=1S/C27H29ClO10/c1-14(29)34-13-23-25(35-15(2)30)27(37-17(4)32)26(36-16(3)31)24(38-23)19-7-10-22(28)20(12-19)11-18-5-8-21(33)9-6-18/h5-10,12,23-27,33H,11,13H2,1-4H3/t23-,24+,25-,26+,27+/m1/s1
InChI KeyIPPDHWALLUPDNH-MMKSVXGCSA-N
Transport InfoProduct name: (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triacetic acid triester
Related Products in Pharmaceutical Intermediates
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol915095-96-42A-3180312
1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)benzyl]benzene1279691-35-82A-3180314
(S)-(5-broMo-2-chlorophenyl)(4-(tetrahydrofuran-3-yloxy)phenyl)Methanone915095-84-02A-3180317
(R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran915095-90-82A-3180319
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-methoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol333359-90-32A-3180320
(2S,3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol1358581-37-92A-3180324
(R)-2-[1-[[[1-[3-[(E)-2-(7-Ch851755-56-12A-3180336
2-Pyrrolidinecarboxamide,1-(hydroxyacetyl)-,(S)-(9CI)96166-39-12A-3180360
3-Oxazolidinecarboxylic acid, 4-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-oxo-2,4-diphenyl-, phenylmethyl ester, (2R,4S)-530441-36-22A-1180365
(3R,3aR,4S,4aR,8aR,9aR)-Dodecahydro-3-methyl-1,7-dioxo-naphtho[2,3-c]furan-4-carboxylic acid900161-05-92A-0180367
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA